Indication
- Bone Mass Increase in Men at High Risk for Fracture receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer
- Bone Mass Increase in Women at High Risk for Fracture receiving Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- Glucocorticoid Induced Osteoporosis in Men & Women at High Risk for Fracture
- Osteoporosis in Men at High Risk for Fracture
- Postmenopausal Osteoporosis at High Risk for Fracture